These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 15354934

  • 1. [Analysis of point mutations in the ygeD, gyrA and parC genes in fluoroquinolones resistant clinical isolates of Chlamydia trachomatis].
    Misiurina OIu, Shipitsina EV, Finashutina IuP, Lazarev VN, Akopian TA, Savicheva AM, Govorun VM.
    Mol Gen Mikrobiol Virusol; 2004; (3):3-7. PubMed ID: 15354934
    [Abstract] [Full Text] [Related]

  • 2. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK, Nair S, Wain J.
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [Abstract] [Full Text] [Related]

  • 3. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ, Cho JK, Kim KS, Tak RB, Kim AR, Kim JW, Im SK, Kim BH.
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [Abstract] [Full Text] [Related]

  • 4. Rapid detection of gyrA and parC mutations in quinolone-resistant Salmonella enterica using Pyrosequencing technology.
    Hopkins KL, Arnold C, Threlfall EJ.
    J Microbiol Methods; 2007 Jan; 68(1):163-71. PubMed ID: 16934351
    [Abstract] [Full Text] [Related]

  • 5. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
    Moon DC, Seol SY, Gurung M, Jin JS, Choi CH, Kim J, Lee YC, Cho DT, Lee JC.
    Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
    [Abstract] [Full Text] [Related]

  • 6. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y, Pei X, Liu X.
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [Abstract] [Full Text] [Related]

  • 7. Role of type II topoisomerase mutations and AcrAB efflux pump in fluoroquinolone-resistant clinical isolates of Proteus mirabilis.
    Saito R, Sato K, Kumita W, Inami N, Nishiyama H, Okamura N, Moriya K, Koike K.
    J Antimicrob Chemother; 2006 Sep; 58(3):673-7. PubMed ID: 16870650
    [Abstract] [Full Text] [Related]

  • 8. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC, Wang HB, Sun ZY, Shen ZY.
    Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):403-7. PubMed ID: 12820918
    [Abstract] [Full Text] [Related]

  • 9. Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis.
    Yokoi S, Yasuda M, Ito S, Takahashi Y, Ishihara S, Deguchi T, Maeda S, Kubota Y, Tamaki M, Fukushi H.
    J Infect Chemother; 2004 Oct 10; 10(5):262-7. PubMed ID: 16163459
    [Abstract] [Full Text] [Related]

  • 10. Mutant-prevention concentrations of enrofloxacin for Escherichia coli isolates from chickens.
    Li Q, Bi X, Diao Y, Deng X.
    Am J Vet Res; 2007 Aug 10; 68(8):812-5. PubMed ID: 17669019
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M, Higa F, Nakasone C, Shinzato T, Akamine M, Haranaga S, Tateyama M, Nakasone I, Yamane N, Fujita J.
    J Antimicrob Chemother; 2006 Dec 10; 58(6):1279-82. PubMed ID: 17056610
    [Abstract] [Full Text] [Related]

  • 12. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN, Adam HJ, Siemens CG, Hoban CJ, Hoban DJ, Zhanel GG.
    J Antimicrob Chemother; 2005 Oct 10; 56(4):769-72. PubMed ID: 16126779
    [Abstract] [Full Text] [Related]

  • 13. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
    Bansal S, Tandon V.
    Int J Antimicrob Agents; 2011 Mar 10; 37(3):253-5. PubMed ID: 21236644
    [Abstract] [Full Text] [Related]

  • 14. Molecular mechanisms of decreased susceptibility to fluoroquinolones in avian Salmonella serovars and their mutants selected during the determination of mutant prevention concentrations.
    Kehrenberg C, de Jong A, Friederichs S, Cloeckaert A, Schwarz S.
    J Antimicrob Chemother; 2007 May 10; 59(5):886-92. PubMed ID: 17369276
    [Abstract] [Full Text] [Related]

  • 15. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, Deb M, Aggarwal P, Rubino S.
    J Antimicrob Chemother; 2006 Dec 10; 58(6):1139-44. PubMed ID: 17071955
    [Abstract] [Full Text] [Related]

  • 16. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003).
    Davies TA, Yee YC, Goldschmidt R, Bush K, Sahm DF, Evangelista A.
    J Antimicrob Chemother; 2006 Mar 10; 57(3):437-42. PubMed ID: 16431861
    [Abstract] [Full Text] [Related]

  • 17. Resistance of different Chlamydia-like organisms to quinolones and mutations in the quinoline resistance-determining region of the DNA gyrase A- and topoisomerase-encoding genes.
    Casson N, Greub G.
    Int J Antimicrob Agents; 2006 Jun 10; 27(6):541-4. PubMed ID: 16697560
    [Abstract] [Full Text] [Related]

  • 18. Rapid detection of gyrA and parC mutations in fluoroquinolone-resistant Neisseria gonorrhoeae by denaturing high-performance liquid chromatography.
    Shigemura K, Shirakawa T, Okada H, Tanaka K, Udaka T, Kamidono S, Arakawa S, Gotoh A.
    J Microbiol Methods; 2004 Dec 10; 59(3):415-21. PubMed ID: 15488283
    [Abstract] [Full Text] [Related]

  • 19. High-level resistance to fluoroquinolones linked to mutations in gyrA, parC, and parE in Salmonella enterica serovar Schwarzengrund isolates from humans in Taiwan.
    Baucheron S, Chaslus-Dancla E, Cloeckaert A, Chiu CH, Butaye P.
    Antimicrob Agents Chemother; 2005 Feb 10; 49(2):862-3. PubMed ID: 15673791
    [No Abstract] [Full Text] [Related]

  • 20. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
    Billal DS, Fedorko DP, Yan SS, Hotomi M, Fujihara K, Nelson N, Yamanaka N.
    J Antimicrob Chemother; 2007 Jan 10; 59(1):28-34. PubMed ID: 17065188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.